feed,title,long_url,short_url
SeekingAlpha,Zymergen expands agreement with Octant on developing breakthrough medicines,https://seekingalpha.com/news/3857020,
SeekingAlpha,ThreeD Capital reports June NAV at $0.99,https://seekingalpha.com/news/3857019,
SeekingAlpha,Monro Inc. gains as investor pushes for strategic review,https://seekingalpha.com/news/3857018,
